Ignite Creation Date:
2024-05-05 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 9:44 AM
Study NCT ID:
NCT00617305
Status:
COMPLETED
Last Update Posted:
2012-07-30
First Post:
2008-02-06
Brief Title:
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor PDE5i Therapy in Pulmonary Arterial Hypertension ATHENA-1
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Organization Data
Organization:
Gilead Sciences
Class:
INDUSTRY
Study ID:
GS-US-300-0117
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gilead Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None